Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

Completed · Phase 3

Conditions studied: Chronic Hepatitis B

In brief

This trial is being conducted as an open-label, extended-term study for patients with chronic hepatitis B who have previously completed an Idenix-sponsored trial with telbivudine.

Key facts

Study ID

NCT00142298

Run by

Novartis Pharmaceuticals

People needed

1869

Starts

2005-03-01

Expected to finish

2009-11-01

Last updated by the study team

2020-08-21

Who can join

Age: 16 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient completed a previous qualifying Idenix-Sponsored trial with telbivudine
• Patient was not discontinued from previous Idenix-Sponsored study
• Other protocol-defined inclusion criteria may apply

You may not qualify if…

• Patient is pregnant or breastfeeding
• Patient is co-infected with hepatitis C, hepatitis D or HIV
• Other protocol-defined exclusion criteria may apply

Where it is running

• Novartis Investigational Site — Phoenix, Arizona, United States
• Novartis Investigational Site — Los Angeles, California, United States
• Novartis Investigational Site — Los Angeles, California, United States
• Novartis Investigational Site — Pasadena, California, United States
• Novartis Investigational Site — Sacramento, California, United States
• Novartis Investigational Site — San Diego, California, United States
• Novartis Investigational Site — San Francisco, California, United States
• Novartis Investigational Site — Sarasota, Florida, United States
• Novartis Investigational Site — Atlanta, Georgia, United States
• Novartis Investigational Site — Honolulu, Hawaii, United States
• Novartis Investigational Site — Chicago, Illinois, United States
• Novartis Investigational Site — Boston, Massachusetts, United States
• Novartis Investigational Site — Ann Arbor, Michigan, United States
• Novartis Investigational Site — St Louis, Missouri, United States
• Novartis Investigational Site — New York, New York, United States
• Novartis Investigational Site — Chapel Hill, North Carolina, United States
• Novartis Investigational Site — Philadelphia, Pennsylvania, United States
• Novartis Investigational Site — Houston, Texas, United States
• Novartis Investigational Site — Richmond, Virginia, United States
• Novartis Investigational Site — Heidelberg, Victoria, Australia
• Novartis Investigational Site — Toronto, Ontario, Canada
• Novartis Investigational Site — Beijing, Beijing Municipality, China
• Novartis Investigational Site — Prague, Czechia
• Novartis Investigational Site — Paris, France
• Novartis Investigational Site — Hanover, Germany

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.